Evaluation of offspring and maternal genetic effects on disease risk using a family-based approach: The "pent" design

American Journal of Epidemiology

Volumn 162, Issue 7, 2005, Pages 676-685

  Mitchell, Laura E ^a   Weinberg, Clarice R ^b  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Alleles; Epidemiologic methods; Genotype; Linkage (genetics); Linkage disequilibrium; Models, genetic; Models, statistical

Indexed keywords

DISEASE;

ARTICLE; CORRELATION ANALYSIS; DISEASE TRANSMISSION; EMBRYO; FAMILY; FEMALE; FETUS; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HIGH RISK POPULATION; HUMAN; INHERITANCE; MALE; MATING TYPE; MOTHER; PARENT; PREGNANCY COMPLICATION; PROGENY; SIMULATION;

AGE OF ONSET; ALLELES; EPIDEMIOLOGIC METHODS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE (GENETICS); LINKAGE DISEQUILIBRIUM; MODELS, GENETIC; MODELS, STATISTICAL; MOTHERS; RISK ASSESSMENT;

EID: 26444557985     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwi249     Document Type: Article

References (27)

1. van der Put NMJ, Steegers-Theunissen RPM, Frosst P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995;346:1070-1.
2. Whitehead AS, Gallagher P, Mills JL, et al. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. QJM 1995;88:763-6.
3. Ou CY, Stevenson RE, Brown VK, et al. 5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 1996;63:610-14.
4. Posey DL, Khoury MJ, Mulinare J, et al. Is mutated MTHFR a risk factor for neural tube defects? Lancet 1996;347:686-9.
5. Mitchell LE. Differentiating between fetal and maternal genotypic effects, using the transmission test for linkage disequilibrium. Am J Hum Genet 1997;60:1006-7.
6. Wilcox AJ, Weinberg CR, Lie RT. Distinguishing the effects of maternal and offspring genes through studies of "case-parent triads." Am J Epidemiol 1998;148:893-901.
7. Weinberg CR, Wilcox AJ, Lie RT. A log-linear approach to case-parent-triad data: assessing the effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting. Am J Hum Genet 1998;62:969-78.
8. Weinberg CR. Studying parents and grandparents to assess genetic contributions to early-onset disease. Am J Hum Genet 2003;72:438-47.
9. Cordell HJ, Barratt BJ, Clayton DG. Case/pseudocontrol analysis in genetic association studies: a unified framework for detection of genotype and haplotype associations, gene-gene and gene-environment interactions, and parent-of-origin effects. Genet Epidemiol 2004;26:167-85.
10. Dempster AP, Laird NM, Rubin DB. Maximum likelihood from incomplete data via the EM algorithm. J R Stat Soc (B) 1977;39:1-28.
11. SAS Institute, Inc. SAS computer program, version 8.01. Cary, NC: SAS Institute, Inc, 1999.
12. Weinberg CR. Allowing for missing parents in genetic studies of case-parent triads. Am J Hum Genet 1999;64:1186-93.
13. Hirschhorn JN, Lohmueller K, Byrne E, et al. A comprehensive review of genetic association studies. Genet Med 2002;4:45-61.
14. Terwilliger JD, Haghighi F, Hiekkalinna TS, et al. A bias-ed assessment of the use of SNPs in human complex traits. Curr Opin Genet Dev 2002;12:726-34.
15. Hoh J, Ott J. Mathematical multi-locus approaches to localizing complex human trait genes. Nat Rev Genet 2003;4:701-9.
16. Moore JH. The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered 2003;56:73-82.
17. Hahn LW, Ritchie MD, Moore JH. Multifactorial dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003;19:376-82.
18. Hao K, Xu X, Laird N, et al. Power estimation for multiple SNP association test of case-control study and application. Genet Epidemiol 2004;26:22-30.
19. Wille A, Hoh J, Ott J. Sum statistics for the joint detection of multiple disease loci in case-control association studies with SNP markers. Genet Epidemiol 2003;25:350-9.
20. Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 2000;151:862-77.
21. US Department of Health and Human Services. Vital statistics of the United States, 1999: natality. Hyattsville, MD: National Center for Health Statistics, Centers for Disease Control and Prevention, 2001. (http://www.cdc.gov/nchs/datawh/statab/unpubd/natality/natab99.htm).
22. Palmer CGS, Turuunen JA, Sinsheimer JS, et al. RHD maternal-fetal genotype incompatibility increases schizophrenia susceptibility. Am J Hum Genet 2002;71:1312-19.
23. Jones MB, Palmour RM, Zwaigenbaum L, et al. Modifier effects in autism at the MAO-A and DBH loci. Am J Med Genet B Neuropsychiatr Genet 2004;126B:58-65.
24. Vefring H, Lie RT, Odegard R, et al. Maternal and fetal variants of genetic thrombophilias and the risk of preeclampsia. Epidemiology 2004;15:317-22.
25. Descamps OS, Bruniaux M, Guilmot PF, et al. Lipoprotein concentrations in newborns are associated with allelic variants in their mothers. Atherosclerosis 2004;172:287-98.
26. Dean J. Oocyte-specific genes regulate follicle formation, fertility and early mouse development. J Reprod Immunol 2002;53:171-80.
27. Wu X, Viveiros MM, Eppig JJ, et al. Zygote arrest 1 (Zar1) is a novel maternal-effect gene critical for the oocyte-to-embryo transition. Nat Genetic 2003;33:187-91.